Expert Opinion on Investigational Drugs, Volume 19, Issue 5 (2010)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 19, Issue 5 (2010)

See all volumes and issues
Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Volume 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994
Download citations Download PDFs Download issue

Reviews

Article
An overview of investigational antiapoptotic drugs with potential application for the treatment of neurodegenerative disorders
Antoni Camins PhD, Francesc Xavier Sureda, Felix Junyent, Ester Verdaguer, Jaume Folch, Carlos Beas-Zarate & Merce Pallas
Pages: 587-604
Published online: 19 Apr 2010
AbstractforAn overview of investigational antiapoptotic drugs with potential application for the treatment of neurodegenerative disorders | Full Text | References | PDF (407.7 KB)
  • 242 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancer
Joanne Edwards PhD
Pages: 605-614
Published online: 05 Apr 2010
AbstractforSrc kinase inhibitors: an emerging therapeutic treatment option for prostate cancer | Full Text | References | PDF (211.6 KB)
  • 308 Views
  • 28 CrossRef citations
  • 0Altmetric
Article
Novel inhibitors in development for hepatocellular carcinoma
Marcus Alexander Wörns MD & Peter Robert Galle MD PhD
Pages: 615-629
Published online: 07 Apr 2010
AbstractforNovel inhibitors in development for hepatocellular carcinoma | Full Text | References | PDF (247 KB)
  • 256 Views
  • 27 CrossRef citations
  • 0Altmetric
Article
The potential role of insulin-like growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer
Cesare Gridelli MD, Antonio Rossi MD, Maria Anna Bareschino MD, Clorinda Schettino MD, Paola Claudia Sacco MD & Paolo Maione MD
Pages: 631-639
Published online: 03 Apr 2010
AbstractforThe potential role of insulin-like growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer | Full Text | References | PDF (206 KB)
  • 158 Views
  • 19 CrossRef citations
  • 0Altmetric
Article
Modulators of the urokinase-type plasminogen activation system for cancer
Ralf Hildenbrand, Heike Allgayer, Alexander Marx & Philipp Stroebel
Pages: 641-652
Published online: 19 Apr 2010
AbstractforModulators of the urokinase-type plasminogen activation system for cancer | Full Text | References | PDF (282.5 KB)
  • 423 Views
  • 56 CrossRef citations
  • 0Altmetric
Article
Is there a future for direct renin inhibitors?
Kunal Chaudhary, Ravi Nistala & Adam Whaley-Connell
Pages: 653-661
Published online: 09 Apr 2010
AbstractforIs there a future for direct renin inhibitors? | Full Text | References | PDF (252.5 KB)
  • 179 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma
Andrew X Zhu
Pages: 663-672
Published online: 03 Apr 2010
AbstractforBeyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma | Full Text | References | PDF (209.1 KB)
  • 365 Views
  • 19 CrossRef citations
  • 0Altmetric

Drug Evaluations

Article
The accumulated experience with the use of mycophenolate mofetil in primary glomerulonephritis
Maria Koukoulaki MD MPhil & Dimitrios S Goumenos MD
Pages: 673-687
Published online: 07 Apr 2010
AbstractforThe accumulated experience with the use of mycophenolate mofetil in primary glomerulonephritis | Full Text | References | PDF (234.8 KB)
  • 287 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Suppression of farnesyltransferase activity in acute myeloid leukemia and myelodysplastic syndrome: current understanding and recommended use of tipifarnib
Pearlie K Epling-Burnette PharmD PhD & Thomas P Loughran Jr MD
Pages: 689-698
Published online: 19 Apr 2010
AbstractforSuppression of farnesyltransferase activity in acute myeloid leukemia and myelodysplastic syndrome: current understanding and recommended use of tipifarnib | Full Text | References | PDF (257.6 KB)
  • 139 Views
  • 19 CrossRef citations
  • 0Altmetric

Explore articles